title: Sigma-1 receptor expression in sensory neurons and the effect of painful peripheral nerve injury.
abstract: BACKGROUND
  The sigma-1 receptor (σ1R), an endoplasmic reticulum chaperone protein, is widely distributed and regulates numerous intracellular processes in neurons. Nerve injury alters the structure and function of axotomized dorsal root ganglion (DRG) neurons, contributing to the development of pain. The σ1R is enriched in the spinal cord and modulates pain after peripheral nerve injury. However, σ1R expression in the DRG has not been studied. We therefore characterized σ1R expression in DRGs at baseline and following spinal nerve ligation (SNL) in rats.
  
  
  RESULTS
  Immunohistochemical (IHC) studies in DRG sections show σ1R in both neuronal somata and satellite glial cells. The punctate distribution of σ1R in the neuronal cytoplasm suggests expression in the endoplasmic reticulum. When classified by neuronal size, large neurons (>1300 μm) showed higher levels of σ1R staining than other groups (700-1300 μm, <700 μm). Comparing σ1R expression in neuronal groups characterized by expression of calcitonin gene-related peptide (CGRP), isolectin-B4 (IB4) and neurofilament-200 (NF-200), we found σ1R expression in all three neuronal subpopulations, with highest levels of σ1R expression in the NF-200 group. After SNL, lysates from L5 DRGs that contains axotomized neurons showed decreased σ1R protein but unaffected transcript level, compared with Control DRGs. IHC images also showed decreased σ1R protein expression, in SNL L5 DRGs, and to a lesser extent in the neighboring SNL L4 DRGs. Neurons labeled by CGRP and NF-200 showed decreased σ1R expression in L5 and, to a lesser extent, L4 DRGs. In IB4-labeled neurons, σ1R expression decreased only in axotomized L5 DRGs. Satellite cells also showed decreased σ1R expression in L5 DRGs after SNL.
  
  
  CONCLUSIONS
  Our data show that σ1R is present in both sensory neurons and satellite cells in rat DRGs. Expression of σ1R is down-regulated in axotomized neurons as well as in their accompanying satellite glial cells, while neighboring uninjured neurons show a lesser down-regulation. Therefore, elevated σ1R expression in neuropathic pain is not an explanation for pain relief after σ1R blockade. This implies that increased levels of endogenous σ1R agonists may play a role, and diminished neuroprotection from loss of glial σ1R may be a contributing factor.
authors.affiliation: Department of Anesthesiology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA. hwu@mcw.edu.
authors.forename: Madhavi L
authors.initials: ML
authors.lastname: Bangaru
authors.forename: Dorothee
authors.initials: D
authors.lastname: Weihrauch
authors.forename: Qing-Bo
authors.initials: QB
authors.lastname: Tang
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Zoga
authors.forename: Quinn
authors.initials: Q
authors.lastname: Hogan
authors.forename: Hsiang-en
authors.initials: HE
authors.lastname: Wu
mesh_terms: D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism; D005727:Ganglia, Spinal / Q000378:metabolism; D005786:Gene Expression Regulation; D008297:Male; D016900:Neurofilament Proteins / Q000378:metabolism; D059348:Peripheral Nerve Injuries / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017480:Receptors, sigma / Q000235:genetics* / Q000378:metabolism*; D027161:Satellite Cells, Perineuronal / Q000378:metabolism; D011984:Sensory Receptor Cells / Q000378:metabolism*; D000097605:Sigma-1 Receptor
chemical_list: D015740:Calcitonin Gene-Related Peptide; D016900:Neurofilament Proteins; D017480:Receptors, sigma; D000097605:Sigma-1 Receptor
references.citation: Glia. 2010 Jan 15;58(2):169-80
references.pmid: 19565659
references.citation: J Pharmacol Exp Ther. 2010 Mar;332(3):1054-63
references.pmid: 19940104
references.citation: Korean J Physiol Pharmacol. 2010 Dec;14(6):359-64
references.pmid: 21311675
references.citation: Anesthesiology. 2004 Aug;101(2):476-87
references.pmid: 15277932
references.citation: Pharmacol Biochem Behav. 2006 Aug;84(4):581-97
references.pmid: 16945406
references.citation: Anesthesiology. 2008 Nov;109(5):879-89
references.pmid: 18946301
references.citation: J Neurosci. 2011 Mar 9;31(10):3536-49
references.pmid: 21389210
references.citation: Pain. 1992 Sep;50(3):355-363
references.pmid: 1333581
references.citation: J Neurosci. 1986 Jun;6(6):1757-70
references.pmid: 3012017
references.citation: Blood. 2010 Jun 10;115(23):4951-62
references.pmid: 20354174
references.citation: J Pharmacol Exp Ther. 1994 Dec;271(3):1583-90
references.pmid: 7996472
references.citation: Pain. 2012 Dec;153(12):2422-2431
references.pmid: 23021150
references.citation: Eur J Pharmacol. 2007 Oct 1;571(2-3):145-51
references.pmid: 17617400
references.citation: Pain. 2000 May;86(1-2):43-53
references.pmid: 10779659
references.citation: Pain. 1998 Oct;78(1):13-26
references.pmid: 9822208
references.citation: J Physiol. 2012 Mar 1;590(5):1261-72
references.pmid: 22183722
references.citation: Trends Neurosci. 2012 Dec;35(12):762-71
references.pmid: 23102998
references.citation: J Mol Neurosci. 2012 Mar;46(3):497-504
references.pmid: 21863315
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14949-54
references.pmid: 15466698
references.citation: J Neurophysiol. 2012 Mar;107(6):1586-97
references.pmid: 22170966
references.citation: CNS Drugs. 2004;18(5):269-84
references.pmid: 15089113
references.citation: Med Res Rev. 2012 Mar;32(2):410-27
references.pmid: 20687157
references.citation: Trends Pharmacol Sci. 2010 Dec;31(12):557-66
references.pmid: 20869780
references.citation: Br J Pharmacol. 2012 Aug;166(8):2289-306
references.pmid: 22404321
references.citation: J Neurochem. 2008 Jan;104(2):558-72
references.pmid: 18173806
references.citation: Eur J Pharmacol. 2005 Mar 21;511(1):73-4
references.pmid: 15777781
references.citation: Brain Res. 2004 May 8;1007(1-2):65-70
references.pmid: 15064136
references.citation: J Pharmacol Exp Ther. 2007 Sep;322(3):1278-85
references.pmid: 17545312
references.citation: Brain Res Brain Res Rev. 2005 Jun;48(3):457-76
references.pmid: 15914252
references.citation: Neuroscience. 2003;120(4):969-77
references.pmid: 12927203
references.citation: J Comp Neurol. 2004 Aug 2;475(4):575-89
references.pmid: 15236238
references.citation: Mol Pain. 2010 Jan 26;6:6
references.pmid: 20102598
references.citation: Neuropsychopharmacology. 2009 May;34(6):1552-66
references.pmid: 19052542
references.citation: Exp Neurol. 2013 Sep;247:383-91
references.pmid: 23333567
references.citation: Expert Opin Ther Targets. 2011 May;15(5):557-77
references.pmid: 21375464
references.citation: J Neurosci. 2012 May 16;32(20):6917-30
references.pmid: 22593060
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):491-6
references.pmid: 11149946
references.citation: Neuron. 2012 Feb 23;73(4):638-52
references.pmid: 22365541
references.citation: J Pharmacol Exp Ther. 2013 Jan;344(1):155-66
references.pmid: 23065135
references.citation: J Neuropathol Exp Neurol. 2004 Mar;63(3):246-54
references.pmid: 15055448
references.citation: Eur J Pharmacol. 2007 Sep 24;571(1):1-7
references.pmid: 17597599
references.citation: J Neurocytol. 1992 Sep;21(9):635-47
references.pmid: 1403009
references.citation: J Pharmacol Exp Ther. 2013 Apr;345(1):161-8
references.pmid: 23386250
references.citation: J Neurosci Res. 2008 Dec;86(16):3644-54
references.pmid: 18655205
references.citation: J Pharmacol Exp Ther. 2000 Jun;293(3):788-98
references.pmid: 10869377
references.citation: J Neurochem. 2007 Sep;102(5):1569-1584
references.pmid: 17509087
references.citation: Anesthesiology. 2006 Jul;105(1):160-8
references.pmid: 16810008
references.citation: Eur J Pharmacol. 2001 Oct 19;429(1-3):23-37
references.pmid: 11698024
references.citation: Eur J Pharmacol. 1990 May 16;180(2-3):361-4
references.pmid: 2163868
references.citation: J Pharmacol Exp Ther. 2010 Feb;332(2):515-24
references.pmid: 19892920
references.citation: Curr Neurovasc Res. 2006 May;3(2):89-98
references.pmid: 16719792
references.citation: Brain. 2011 Mar;134(Pt 3):732-46
references.pmid: 21278085
references.citation: Neurosci Lett. 1995 May 5;190(2):137-9
references.pmid: 7644123
references.citation: FASEB J. 2008 Jan;22(1):93-104
references.pmid: 17720801
references.citation: Br J Pharmacol. 2009 Jun;157(4):666-73
references.pmid: 19422393
references.citation: Brain Res. 2003 Jan 24;961(1):92-9
references.pmid: 12535781
references.citation: J Neurophysiol. 2002 Jun;87(6):2867-79
references.pmid: 12037190
references.citation: Eur J Pharmacol. 1990 Apr 25;179(3):441-5
references.pmid: 2163857
references.citation: Biochim Biophys Acta. 2013 Apr;1830(4):3082-94
references.pmid: 23298811
references.citation: Cell. 2007 Nov 2;131(3):596-610
references.pmid: 17981125
references.citation: J Neurosci. 2001 Apr 15;21(8):RC140
references.pmid: 11306646
references.citation: J Pain. 2010 Mar;11(3):280-6
references.pmid: 19945356
references.citation: Neuroscience. 2000;97(1):155-70
references.pmid: 10771347
references.citation: Histochem Cell Biol. 2011 Jun;135(6):627-37
references.pmid: 21573736
references.citation: Pharmacol Ther. 2009 Nov;124(2):195-206
references.pmid: 19619582
references.citation: Pain. 2009 Oct;145(3):294-303
references.pmid: 19505761
references.citation: Br J Pharmacol. 2011 Aug;163(8):1707-20
references.pmid: 21391983
references.citation: Anesthesiology. 2009 Aug;111(2):381-92
references.pmid: 19602958
references.citation: J Pharmacol Exp Ther. 2011 Oct;339(1):152-60
references.pmid: 21715562
references.citation: Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4993-5002
references.pmid: 18641291
references.citation: Synapse. 1989;4(1):1-10
references.pmid: 2549651
references.citation: Br J Pharmacol. 2006 Jun;148(4):490-8
references.pmid: 16682960
references.citation: Life Sci. 2011 Dec 5;89(23-24):875-7
references.pmid: 21989208
references.citation: J Neurotrauma. 2011 May;28(5):831-40
references.pmid: 21332255
references.citation: Pain. 2009 Jun;143(3):252-261
references.pmid: 19375855
references.citation: J Pharmacol Exp Ther. 2002 Mar;300(3):1070-4
references.pmid: 11861817